The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 4.50 (1.382%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 328.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

Fri, 28th Jan 2022 16:59

(Alliance News) - Stocks in London ended a volatile week on a downbeat note, with investors digesting a hawkish US Federal Reserve meeting and looking ahead to a likely interest rate hike from the Bank of England next week.

The FTSE 100 index closed down 88.24 points, or 1.2%, at 7,466.07 on Friday, falling 0.4% over the course of the week.

The FTSE 250 ended down 211.27 points, or 1.0%, at 21,643.30, down 2.8% for the week-to-date, and the AIM All-Share closed down 4.13 points, or 0.4%, at 1,082.51, finishing the week overall 4.4% lower.

The Cboe UK 100 ended down 1.1% at 742.35, the Cboe UK 250 closed down 0.7% at 19,470.10, and the Cboe Small Companies ended down 0.5% at 15,453.57.

In European equities on Friday, the CAC 40 in Paris ended down 0.8% and the DAX 40 in Frankfurt ended down 1.3%.

"After the strong gains of yesterday, European markets have slipped back heading into the weekend, with the FTSE100 slipping back into negative territory for the week, ending with a slightly more defensive posture, as telecoms and utilities outperform," said Michael Hewson, chief market analyst at CMC Markets.

Telecommunications firms BT and Vodafone ended up 1.8% and 1.2% respectively.

"This week's gyrations appear to be symptomatic of a market that is struggling to look through the consequences of central banks who are more concerned about containing increased inflation risk, than they are with supporting economic growth. When you throw geopolitics into the mix in the form of conflict risk in eastern Europe, and you have a heady cocktail of risks," Hewson added.

Germany's DAX bore the brunt of Friday's losses after data showed the country's economy contracted in the final months of 2021.

On an annual basis, gross domestic product grew 1.4% in the final three months of 2021, slowing from growth of 2.9% posted in the third quarter. The fourth-quarter annual increase missed market consensus, cited by FXStreet, of 1.8% growth.

However, on a quarterly basis, German GDP fell 0.7% in the three months to December 31 from the three months to September 30, having grown by 1.7% in the third quarter from the second. The figure missed forecasts for a contraction of 0.3%.

The euro stood at USD1.1163 at the European equities close Friday, struggling against USD1.1152 at the same time on Thursday.

Sterling advanced, meanwhile. The pound was quoted at USD1.3422 at the London equities close Friday, higher compared to USD1.3393 at the close on Thursday.

The pound was higher as investors switch focus from a hawkish Federal Reserve and look towards a likely interest rate hike from the Bank of England next Thursday.

"While the ECB and RBA are unlikely to make policy changes, the Bank of England is expected to hike interest rates 25 basis points on Thursday, as it looks to tighten policy for the second time in less than two months," said Fawad Razaqzada, market analyst at ThinkMarkets.

Against the yen, the dollar was trading at JPY115.18, down compared to JPY115.42 late Thursday.

Brent oil was quoted at USD90.59 a barrel at the London equities close Friday, up from USD89.88 late Thursday.

In New York, volatility was continuing into the end of the week, with the Dow Jones up 0.1% in morning trade on Friday, the S&P 500 index up 0.9%, and the Nasdaq Composite up 1.6%.

Boosting the Nasdaq was tech heavyweight Apple, shares soaring 5.7% after reporting a strong start to its financial year.

For the three months ended December 25, net income rose 20% to USD34.63 billion from USD28.76 billion the same period a year before. This was on sales which continued to break records, growing 11% year-on-year to USD123.95 billion from USD111.44 billion, also beating market forecasts of sales amounting to USD119.0 billion.

In London, online grocer Ocado finished at the bottom of the FTSE 100, down 7.6%. Ocado said its ongoing legal battle with US rival Autostore Technology has been put on hold by a German court after questions were raised over the action.

Munich District Court suspended proceedings brought by Ocado for an order to block the sale of AutoStore's B1 robot in Germany, amid concerns about Ocado's intellectual property rights. The court considered that, despite Ocado having made significant last-minute amendments to the claims for its utility models, they are likely to be invalid.

It said this is because the claims are seeking to cover more than had been disclosed in the application for the utility models as originally filed, and told Ocado it is trying to make a claim over technology it did not invent.

Miner Polymetal International ended down 4.2% amid weak prices for precious metals. Gold was quoted at USD1,784.78 an ounce at the London equities close Friday against USD1,794.49 at the close on Thursday.

Phoenix Group Holdings fell 2.8% after abrdn confirmed it sold 40.0 million shares in the insurer for GBP264 million.

The shares were sold at 660 pence per share, and the total sale represents a 4% stake in Phoenix. Plans for the sale were first announced late Thursday. abrdn said it intends to return the cash to its shareholders, with the timing of the return to be announced after the company's results on March 1.

Abrdn shares ended 1.6% higher.

Convatec rose 3.1% in the FTSE 250 after agreeing to acquire US-focused medical device company Triad Life Sciences for USD125 million. The acquisition, therefore, serves as an entry into the "rapidly-growing" wound biologics segment for ConvaTec, a Reading, Berkshire-headquartered medical products and technologies firm.

Oxford Biomedica fell 10% after agreeing to acquire a majority ownership in a newly formed business in the US focused on adeno-associated viruses which are known infect humans and other primates.

The Oxford-based gene and cell therapy company said it has agreed with Massachusetts-based genetic medicines company Homology Medicines Inc to acquire an 80% ownership interest in the newly formed Oxford Biomedica Solutions for USD175 million. Homology will hold the remaining 20% ownership.

Oxford Biomedica added that it will raise total gross proceeds of GBP80 million through an initial issue of 4.9 million shares at 50 pence per share, plus the issue of additional shares at a later date to make up the rest. The net proceeds will fund the company's existing capital requirements, cover the expenses of the transaction and provide additional working capital for the group.

Elsewhere in London, Sabre Insurance rose 12% after signing a new contract to provide taxi underwriting services to Freeway Insurance Services. The Surrey, England-based motor insurance underwriters said it has become the exclusive underwriter for policies issued by Freeway's managing general agent for five years from March 1, 2022.

Monday's UK corporate calendar has a trading statement from Evraz and full-year results from Porvair and Sthree.

The economic calendar on Monday has eurozone gross domestic product at 1000 GMT and German inflation at 1300 GMT. Stock markets in China will be shut next week to celebrate Chinese new year.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
29 Apr 2024 16:58

LONDON MARKET CLOSE: FTSE 100 as investors look to Fed rate decision

(Alliance News) - The FTSE 100 in London closed higher on Monday, outperforming its European counterparts, as investors eye this week's interest rate decision from the US Federal Reserve.

Read more
29 Apr 2024 10:42

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumps

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
29 Apr 2024 08:09

Oxford Biomedica confident as it moves away from vaccine era

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.

Read more
22 Apr 2024 14:45

UK earnings, trading statements calendar - next 7 days

Tuesday 23 April 
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Quilter PLCQ1 Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Apr 2024 09:43

LONDON BROKER RATINGS: HSBC likes Haleon, cuts Flutter to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Mar 2024 17:09

EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Mar 2024 16:22

Oxford Biomedica shares rise on post-acquisition guidance

(Sharecast News) - Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.

Read more
5 Mar 2024 08:57

LONDON BROKER RATINGS: Barclays cuts Bank of Ireland to 'equal weight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Feb 2024 11:34

EnSilica hires new chief financial officer from Oxford Biomedica

(Alliance News) - EnSilica PLC on Monday said it has appointed a new chief financial officer, who will join the company and board in May.

Read more
29 Jan 2024 12:35

IN BRIEF: Institut Merieux ups stake in Oxford BioMedica toward 10%

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy - Completes purchase of ABL Europe SAS from Institut Merieux SA, cementing the partnership between Oxford BioMedica and Institut Merieux. ABL is a cell and gene therapy contract development and manufacturing organization with facilities in Lyon and Strasbourg in France. For the EUR15 million acquisition, Oxford BioMedica will issue 3.1 million new shares to Lyon-based Institut Merieux at a price of 407.4 pence, well above its current market price. This is a 3.2% stake, and Institut Merieux already had 3.3%, giving it a total 6.5% holding. Oxford BioMedica says Institut Merieux intends to raise this to 10.0% by the end of the September.

Read more
7 Dec 2023 21:10

Oxford BioMedica posts optimistic outlook on uptick in contract value

(Alliance News) - Oxford BioMedica PLC on Thursday said it is on track to achieve its guidance for the year, amid an uptick in current contracted value and growth supported by new orders.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
4 Dec 2023 10:32

Oxford BioMedica buys ABL Europe for consideration of EUR15 million

(Alliance News) - Oxford BioMedica PLC on Monday said that it has entered a sale and purchase agreement with TSGH SAS for the acquisition of ABL Europe SAS.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.